Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P62988 (
Ubiquitin
)
4,326
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ubiquitin
-dependent degradation plays an important role in the negative regulation of TGF-beta signaling. Here, we identify Tiul1 (for
TGIF
interacting ubiquitin ligase 1), a novel E3 ubiquitin ligase that inhibits TGF-beta signaling by targeting both the activated receptor and Smad2 for degradation. Tiul1 associates constitutively with Smad7 and induces degradation of the activated type I receptor without affecting the expression levels of Smad7. Tiul1 can also interact with Smad2 and the nuclear corepressor
TGIF
upon activation of TGF-beta signaling. Like Smad7, the steady-state levels of
TGIF
are not affected by Tiul1, but the interaction of Tiul1 with
TGIF
allows this ubiquitin ligase to target Smad2 for degradation. Consistent with this, overexpression of Tiul1 suppressed TGF-beta-induced growth arrest and transcriptional responses. In addition, silencing of Tiul1 or
TGIF
genes by siRNA resulted in suppression of the TGF-beta-dependent degradation of Smad2 and an enhancement of TGF-beta-mediated gene expression. These results reveal a new role for
TGIF
as a component of a ubiquitin ligase complex that mediates the degradation of Smad2 in response to TGF-beta signaling.
...
PMID:The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. 1535 84